Patents-Review.com
ClassID:

20956 ⎘

A61K38/1883 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor

Recent Application in this class:
#1
20260053891
2026-02-26

METHODS AND COMPOSITIONS FOR TREATING CANCER

 #2
20260027184
2026-01-29

METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION

 #3
20250367152
2025-12-04

Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto

 #4
20250360078
2025-11-27

EXTENDED RELEASE OF NEUREGULIN FOR TREATING HEART FAILURE

 #5
20250339493
2025-11-06

METHODS OF USING NEUREGULIN-4 COMPOUNDS

 #6
20250262275
2025-08-21

NEUREGULIN BASED METHODS FOR TREATING HEART FAILURE

 #7
20250241989
2025-07-31

Neuregulin for Protection Against Respiratory Viral Infection and Post-Viral Disease

 #8
20250228917
2025-07-17

METHODS OF TREATING FIBROSIS AND ARRHYTHMIA WITH A NEUREGULIN-1 FUSION PROTEIN

 #9
20250144175
2025-05-08

CHIMERIC PROTEINS FOR TREATMENT OF ACUTE RADIATION SYNDROME

 #10
20250073306
2025-03-06

FORMULA OF NEUREGULIN PREPARATION

 #11
20240366725
2024-11-07

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

 #12
20240358634
2024-10-31

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

 #13
20240316154
2024-09-26

HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME

 #14
20240075103
2024-03-07

EXTENDED RELEASE OF NEUREGULIN FOR IMPROVED CARDIAC FUNCTION

 #15
20240009274
2024-01-11

Use of NRG-1Beta1 for Detection and/or Treatment of Multiple Sclerosis

 #16
20230272066
2023-08-31

Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disorders

 #17
20230117985
2023-04-20

USE OF NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY

 #18
20230083149
2023-03-16

METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY USING NEUREGULIN, AND COMPOSITION

 #19
20230000988
2023-01-05

Therapeutic Protein Formulations

 #20
20220362339
2022-11-17

Compositions and methods for treating heart failure

 #21
20220354928
2022-11-10

METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE

 #22
20220296680
2022-09-22

TREATMENT AND PREVENTION OF CARDIORENAL DAMAGE

 #23
20220280607
2022-09-08

Treatment of Heart Defects and Conditions in Pediatric Patients

 #24
20220241433
2022-08-04

NERVE REGENERATION

 #25
20220211813
2022-07-07

METHODS FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C

 #26
20220211613
2022-07-07

Extended release of neuregulin for treating heart failure

 #27
20220133855
2022-05-05

Neuregulin based methods for treating heart failure

 #28
20220110980
2022-04-14

PRIMED MUSCLE PROGENITOR CELLS AND USES THEREOF

 #29
20220096599
2022-03-31

METHOD FOR PREVENTING, TREATING OR DELAYING MYOCARDIAL DAMAGE USING NEUREGULIN AND COMPOSITION

 #30
20220040096
2022-02-10

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

 #31
20220040095
2022-02-10

Auris formulations for treating otic diseases and conditions

 #32
20210401938
2021-12-30

METHODS FOR TREATING CARDIAC INJURY

 #33
20210347840
2021-11-11

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTS

 #34
20210299078
2021-09-30

Inducing proliferation of cardiomyocytes and therapeutic uses related thereto

 #35
20210128687
2021-05-06

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

 #36
20210113661
2021-04-22

Formula of neuregulin preparation

 #37
20210077579
2021-03-18

Method of effecting neuroprotection using soluble neuregulin isoforms

 #38
20210060128
2021-03-04

METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS

 #39
20210009716
2021-01-14

Synthetic proteins and therapeutic uses thereof

 #40
20200368318
2020-11-26

COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING CNS NEUROLOGICAL INJURY

 #41
20200368317
2020-11-26

METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE

 #42
20200353043
2020-11-12

Methods for treating diseases mediated by ERBB4-positive pro-inflammatory macrophages

 #43
20200338165
2020-10-29

THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE

 #44
20200230051
2020-07-23

Auris formulations for treating otic diseases and conditions

 #45
20200131262
2020-04-30

Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders

 #46
20200121596
2020-04-23

Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction

 #47
20200009228
2020-01-09

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

 #48
20190307848
2019-10-10

Method of effecting neuroprotection using soluble neuregulin isoforms

 #49
20190307678
2019-10-10

Auris formulations for treating OTIC diseases and conditions

 #50
20190269759
2019-09-05

Methods for detecting cardiac damage

 #51
20190256846
2019-08-22

Modulation of TJP1 expression to regulate regeneration of heart cells

 #52
20190240145
2019-08-08

Extended release of neuregulin for treating heart failure

 #53
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

 #54
20180353534
2018-12-13

Methods for treating sarcopenia and frailty

 #55
20180318391
2018-11-08

ERBB4 activator screening assay

 #56
20180311312
2018-11-01

Use of a Neuregulin to Treat Peripheral Nerve Injury

 #57
20180311281
2018-11-01

Primed muscle progenitor cells and uses thereof

 #58
20180303904
2018-10-25

Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure

 #59
20180296642
2018-10-18

METHODS FOR TREATING CARDIAC INJURY

 #60
20180280477
2018-10-04

Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart Failure

 #61
20180271944
2018-09-27

Methods for treating diseases mediated by ErbB4-positive pro-inflammatory macrophages

 #62
20180104311
2018-04-19

Neuregulin based methods for treating heart failure

 #63
20180066033
2018-03-08

TARGETING TRASTUZUMAB-RESISTANT HER2+ BREAST CANCER WITH A HER3-TARGETING NANOPARTICLE

 #64
20180055909
2018-03-01

Method for achieving desired glial growth factor 2 plasma levels

 #65
20180028610
2018-02-01

Methods for detecting cardiac damage

 #66
20170368140
2017-12-28

Uses of neuregulin in preventing, treating or delaying ventricular arrhythmia, and composition thereof

 #67
20170360889
2017-12-21

NEUREGULIN BASED METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES

 #68
20170333574
2017-11-23

ROOT CAUSE CURE AND PREVENTATIVE MEASURE FOR SCHIZOPHRENIA AND OTHER MENTAL ILLNESS

 #69
20170333529
2017-11-23

NEUREGULIN IN THE TREATMENT OF FIBROTIC DISORDERS

 #70
20170326204
2017-11-16

Compositions and methods for treating heart failure

 #71
20170252406
2017-09-07

Compositions and methods for treatment during non-acute periods following CNS neurological injury

 #72
20170232068
2017-08-17

Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure

 #73
20170189489
2017-07-06

CARDIAC MUSCLE FUNCTION AND MANIPULATION

 #74
20170035849
2017-02-09

Method of effecting neuroprotection using soluble Neuregulin isoforms

 #75
20170035848
2017-02-09

TREATMENT OF NEPHROPATHY

 #76
20170007671
2017-01-12

Formula of neuregulin preparation

 #77
20160367634
2016-12-22

Method for achieving desired glial growth factor 2 plasma levels

 #78
20160346353
2016-12-01

Use of Neuregulin to Treat Peripheral Nerve Injury

 #79
20160326250
2016-11-10

Methods, kits and devices for promoting cardiac regeneration

 #80
20160317619
2016-11-03

USE OF NEUREGULIN-4 FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND NECROTIZING ENTEROCOLITIS

 #81
20160279201
2016-09-29

Methods of treating metabolic disorders

 #82
20160263192
2016-09-15

Methods for detecting cardiac damage

 #83
20160243028
2016-08-25

Auris formulations for treating otic diseases and conditions

 #84
20160129084
2016-05-12

Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure

 #85
20160113999
2016-04-28

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

 #86
20160113998
2016-04-28

Methods for treating congestive heart failure

 #87
20160095903
2016-04-07

Extended release of neuregulin for improved cardiac function

 #88
20160095902
2016-04-07

Auris formulations for treating otic diseases and conditions

 #89
20160089329
2016-03-31

Extended release of neuregulin for treating heart failure

 #90
20160060316
2016-03-03

Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

 #91
20160009774
2016-01-14

Neuregulin peptides and their use

 #92
20160008432
2016-01-14

Neuregulin based methods for treating heart failure

 #93
20150343023
2015-12-03

METHODS FOR CARDIOPROTECTION AND CARDIOREGENERATION WITH DIMERS OF EGF FAMILY LIGANDS

 #94
20150284440
2015-10-08

Compositions and methods for treating heart failure in diabetic patients

 #95
20150239948
2015-08-27

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

 #96
20150216936
2015-08-06

Use of a Neuregulin to Treat Peripheral Nerve Injury

 #97
20150202266
2015-07-23

COMPOSITION AND METHOD FOR REDUCING TISSUE DAMAGE FROM INFLAMMATORY DISORDER OR PATHOGENIC INFECTION

 #98
20150196621
2015-07-16

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROINJURY AND METHODS OF USE THEREOF

 #99
20150183844
2015-07-02

CHIMERIC NEUREGULINS AND METHOD OF MAKING AND USE THEREOF

 #100
20150094263
2015-04-02

Use of Neuregulin to Treat Peripheral Nerve Injury

 #101
20150080302
2015-03-19

NEUREGULIN ISOFORMS, NEUREGULIN POLYPEPTIDES AND USES THEREOF

 #102
20150065418
2015-03-05

Neuregulin based methods and compositions for treating cardiovascular diseases

 #103
20140364366
2014-12-11

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

 #104
20140255384
2014-09-11

Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin

 #105
20140248334
2014-09-04

Peptides that target dorsal root ganglion neurons

 #106
20140227247
2014-08-14

Chimeric neuregulins and method of making and use thereof

 #107
20140178404
2014-06-26

Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis

 #108
20140135265
2014-05-15

Neuregulin peptides and their use

 #109
20140088009
2014-03-27

Chimeric neuregulins and method of making and use thereof

 #110
20140086897
2014-03-27

Chimeric neuregulins and method of making and use thereof

 #111
20140030251
2014-01-30

Method for treating malaria

 #112
20130345131
2013-12-26

Method for achieving desired glial growth factor 2 plasma levels

 #113
20130324466
2013-12-05

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

 #114
20130287728
2013-10-31

Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency

 #115
20130196911
2013-08-01

Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands

 #116
20130095053
2013-04-18

Regulation of skin pigmentation by neuregulin-1 (NRG-1)

 #117
20130040879
2013-02-14

Methods For Treating Congestive Heart Failure

 #118
20120214737
2012-08-23

METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2

 #119
20120065130
2012-03-15

Methods for treating congestive heart failure

 #120
20120039881
2012-02-16

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

 #121
20120009244
2012-01-12

NEUROD1 GENE EXPRESSION IN NON-ENDOCRINE PANCREATIC EPITHELIAL CELLS (NEPECs)

 #122
20110269682
2011-11-03

Compositions and methods for treatment during non-acute periods following CNS neurological injury

 #123
20110230412
2011-09-22

Neuregulin peptides and their use

 #124
20110229444
2011-09-22

Neuregulin And Cardiac Stem Cells

 #125
20110212108
2011-09-01

NEUREGULIN/ERBB SIGNALING AND INTEGRIN

 #126
20110189263
2011-08-04

Peptides that target dorsal root ganglion neurons

 #127
20110166068
2011-07-07

Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure

 #128
20110135595
2011-06-09

Neuregulin based methods and compositions for treating cardiovascular disease

 #129
20110124561
2011-05-26

Use of a neuregulin to treat peripheral nerve injury

 #130
20110085976
2011-04-14

Methods for detecting cardiac damage

 #131
20100316626
2010-12-16

METHODS FOR TREATMENT AND DIAGNOSIS OF PSYCHIATRIC DISORDERS

 #132
20100286043
2010-11-11

USE OF NEUREGULIN-1 IN REDUCING BRAIN DAMAGE

 #133
20100267618
2010-10-21

Methods for treating congestive heart failure

 #134
20100256066
2010-10-07

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

 #135
20100215722
2010-08-26

Tissue Regeneration II

 #136
20100136004
2010-06-03

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

 #137
20100029559
2010-02-04

Method for achieving desired glial growth factor 2 plasma levels

 #138
20090306225
2009-12-10

Auris formulations for treating otic diseases and conditions

 #139
20090291893
2009-11-26

Compositions for the prevention and treatment of neuroinjury and methods of use thereof

 #140
20090221495
2009-09-03

Treatments for neurological disorders

 #141
20080299655
2008-12-04

Methods of inducing tubulogenesis and/or branching morphogenesis of kidney cell cultures

 #142
20080031880
2008-02-07

Use of ErbB receptor ligands in treating diabetes

 #143
20070264254
2007-11-15

Cardiac muscle function and manipulation

 #144
20070196379
2007-08-23

Methods for treating congestive heart failure

 #145
20070190127
2007-08-16

Extended release of neuregulin for improved cardiac function

 #146
20070129296
2007-06-07

Cardiac muscle function and manipulation

 #147
20070054851
2007-03-08

Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases

 #148
20060199767
2006-09-07

Cardiac muscle function and manipulation

 #149
20060194734
2006-08-31

Cardiac muscle function and manipulation

 #150
20060029605
2006-02-09

Use of ErbB receptor ligands in treating diabetes

 #151
20060019888
2006-01-26

Neuregulin based methods and compositions for treating cardiovascular diseases

 #152
20060014288
2006-01-19

NERVE REGENERATION

 #153
20050261186
2005-11-24

Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2

 #154
20050226871
2005-10-13

Compositions and methods for promoting nerve regeneration

 #155
20050074875
2005-04-07

Induction of tubular morphogenesis using pleiotrophin